Brazil health regulator approves emergency use of Johnson & Johnson COVID-19 vaccine
By Syndicated ContentMar 31, 2021 | 2:44 PM
RIO DE JANEIRO (Reuters) – Brazil health regulator Anvisa on Wednesday said it approved emergency use of the COVID-19 vaccine developed by Johnson & Johnson subsidiary Janssen.
For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at (616) 392-3121.